OrganoTherapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 4

OrganoTherapeutics General Information

Description

Developer of therapeutics intended to target neurodegenerative diseases, with a focus on Parkinson's. The company utilizes complex, human patient-specific models to support the development of treatments for diseases such as Parkinson's, enabling researchers to advance therapeutics for neurodegeneration.

Contact Information

Website
www.organo-therapeutics.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 29 Rue Henri Koch
  • Esch-sur-Alzette, 4354
  • Luxembourg
+352 27
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Transpharmation
Vertical(s)
Artificial Intelligence & Machine Learning
Corporate Office
  • 29 Rue Henri Koch
  • Esch-sur-Alzette, 4354
  • Luxembourg
+352 27

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrganoTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 23-Oct-2026 Completed Generating Revenue
4. Merger/Acquisition Cancelled Startup
3. Accelerator/Incubator 01-Jan-2021 Completed Startup
2. Accelerator/Incubator 15-Oct-2020 $58.8K $59.9K Completed Startup
1. Accelerator/Incubator 01-Jan-2020 $1.11K $1.11K Completed Startup
To view OrganoTherapeutics’s complete valuation and funding history, request access »

OrganoTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutics intended to target neurodegenerative diseases, with a focus on Parkinson's. The company utiliz
Biotechnology
Esch-sur-Alzette, Luxembourg
9 As of 2026

San Francisco, CA
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OrganoTherapeutics Competitors (2)

One of OrganoTherapeutics’s 2 competitors is Herophilus, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Herophilus Formerly VC-backed San Francisco, CA
a:head bio Venture Capital-Backed Vienna, Austria
You’re viewing 2 of 2 competitors. Get the full list »

OrganoTherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

OrganoTherapeutics FAQs

  • When was OrganoTherapeutics founded?

    OrganoTherapeutics was founded in 2019.

  • Where is OrganoTherapeutics headquartered?

    OrganoTherapeutics is headquartered in Esch-sur-Alzette, Luxembourg.

  • What is the size of OrganoTherapeutics?

    OrganoTherapeutics has 9 total employees.

  • What industry is OrganoTherapeutics in?

    OrganoTherapeutics’s primary industry is Biotechnology.

  • Is OrganoTherapeutics a private or public company?

    OrganoTherapeutics is a Private company.

  • What is OrganoTherapeutics’s current revenue?

    The current revenue for OrganoTherapeutics is .

  • How much funding has OrganoTherapeutics raised over time?

    OrganoTherapeutics has raised $59.9K.

  • Who are OrganoTherapeutics’s competitors?

    Herophilus and a:head bio are competitors of OrganoTherapeutics.

  • When was OrganoTherapeutics acquired?

    OrganoTherapeutics was acquired on 23-Oct-2026.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process